Effects of chronic treatment with gold nanoparticles on inflammatory responses and oxidative stress in Mdx mice

Duchenne muscular dystrophy (DMD) is an X-linked recessive hereditary myopathy characterised by progressive muscle degeneration in male children. As a consequence of DMD, increased inflammation and oxidative stress occur in muscle tissue along with morphological changes. Several studies have reporte...

Full description

Saved in:
Bibliographic Details
Published in:Journal of drug targeting 2020-01, Vol.28 (1), p.46-54
Main Authors: Haupenthal, Daniela Pacheco dos Santos, Possato, Jonathann Corrêa, Zaccaron, Rubya Pereira, Mendes, Carolini, Rodrigues, Matheus Scarpatto, Nesi, Renata Tiscoski, Pinho, Ricardo Aurino, Feuser, Paulo Emilio, Machado-de-Ávila, Ricardo Andrez, Comim, Clarissa M., Silveira, Paulo Cesar Lock
Format: Article
Language:English
Subjects:
Duchenne muscular dystrophy
gold nanoparticles
inflammation
Mdx
oxidative stress
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Duchenne muscular dystrophy (DMD) is an X-linked recessive hereditary myopathy characterised by progressive muscle degeneration in male children. As a consequence of DMD, increased inflammation and oxidative stress occur in muscle tissue along with morphological changes. Several studies have reported anti-inflammatory and antioxidant effects of gold nanoparticles (GNP) in muscle injury models. The objective of this study was to evaluate these effects along with the impacts of the disease on histopathological changes following chronic administration of GNP to Mdx mice. Two-month-old Mdx mice were separated into five groups of eight individuals each, as follows: wild-type (WT), Mdx-modified without treatment, Mdx + 2.5 mg/kg GNP, Mdx + 7.0 mg/kg GNP and Mdx + 21 mg/kg GNP. GNP with a mean diameter of 20 nm were injected subcutaneously at concentrations of 2.5, 7.0 and 21 mg/kg. Treatments continued for 30 d with injections administered at 48-h intervals. Twenty-four hours after the last injection, the animals were killed and the central region of the gastrocnemius muscle was surgically removed. Chronic administration of GNP reduced inflammation in the gastrocnemius muscle of Mdx mice and reduced morphological alterations due to inflammatory responses to muscular dystrophy. In addition, GNP also demonstrated antioxidant potential by reducing the production of reactive oxygen and nitrogen species, reducing oxidative damage and improving antioxidant activity.
ISSN:1061-186X
1029-2330
DOI:10.1080/1061186X.2019.1613408